What is the frequency of cardiovascular risk factors and co-morbidity in patients with rheumatic diseases?

被引：0
|
作者：
Bertin, Philippe [1 ]
机构：
[1] CHU Dupuytren, Serv Therapeut & Rhumatol, F-87000 Limoges, France
来源：
PRESSE MEDICALE | 2006年 / 35卷 / 09期
关键词：
D O I：
10.1016/S0755-4982(06)74935-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Analysis of national data from the health ministry programme of reduction of the cardiovascular risks (2002-2005) shows a high frequency of cardiovasculor disease and cardiovascular risk factors in the general population. It is of interest to analyse these data in relation to the practice of rheumotology In addition, the frequency of cardiovascular pathologies is higher in patients with rheumatoid arthritis and spondylorthropathy These notions ore also very important since these two populations are often treated with non-steroid(71 anti-inflammatory drugs for a long duration. General knowledge shown in this article concerning the Cardiovascular risk factors and co-morbidities in the patients with rheumatic pathologies allows, within the context of a therapeutic decisionol strategy in rheumotology a better estimation of the individual benefit/risk ratio of each prescription and more particularly that of non-steroidal antiinflammatory drugs.
引用
收藏
页码：5 / 9
页数：5
相关论文
共 50 条
  • [21] The importance of co-morbidity and environmental risk factors for the development of migraine
    H Le
    P Tfelt-Hansen
    A Skytthe
    KO Kyvik
    J Olesen
    [J]. The Journal of Headache and Pain, 2013, 14
  • [22] The importance of co-morbidity and environmental risk factors for the development of migraine
    Le, H.
    Tfelt-Hansen, P.
    Skytthe, A.
    Kyvik, K. O.
    Olesen, J.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2013, 14
  • [23] Cardiovascular Disease Risk in Patients with Rheumatic Diseases
    Mackey, Rachel H.
    Kuller, Lewis H.
    Moreland, Larry W.
    [J]. CLINICS IN GERIATRIC MEDICINE, 2017, 33 (01) : 105 - +
  • [24] UNDERDIAGNOSIS OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN RHEUMATIC DISEASES
    Cecilia Reynosa-Silva, Ileana
    Angel Galarza-Delgado, Dionicio
    Jazmin Colunga-Pedraza, Iris
    Ramon Azpiri-Lopez, Jose
    de Jesus Hernandez-Galarza, Ivan
    Paola Cuellar-Calderon, Karla
    Castro-Gonzalez, Marielva
    Marlene Martinez-Flores, Carolina
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 637 - 638
  • [25] CO-MORBIDITY BETWEEN DEPRESSION AND CARDIOVASCULAR DISEASE
    Halaris, A.
    [J]. PSYCHIATRY AND THE NEUROSCIENCES: INTERNATIONAL PERSPECTIVES, 2011, : 163 - 169
  • [26] Psychosocial factors and psychiatric co-morbidity in patients attempting suicide
    Katre, Prathibha
    Matcheswalla, Y. A.
    Pathan, Rahim
    Patil, Vanshree
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (05) : S55 - S56
  • [27] CARDIOVASCULAR CO-MORBIDITY AMONG PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Dunn, Terence Sean
    Lenneman, Carrie
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1785 - 1785
  • [28] Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes
    Mody, Reema
    Kalsekar, Iftekhar
    Kavookjian, Jan
    Iyer, Shrividya
    Rajagopalan, Rukmini
    Pawar, Vivek
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (02) : 75 - 83
  • [29] Inflammation and endothelial dysfunction in depression: factors contributing to cardiovascular disease co-morbidity
    Halaris, A.
    Fareed, J.
    Piletz, J.
    Litinas, E.
    Iqbal, O.
    Hoppensteadt, D.
    Tobin, E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 614 - 614
  • [30] Medical co-morbidity risk factors and barriers to care for people with schizophrenia
    Muir-Cochrane, E.
    [J]. JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2006, 13 (04) : 447 - 452
12345